BECN1 and colonic neoplasm: Moreover, reduced levels of Beclin 1 protein have been correlated to poor patient outcome in many tumor types, such as esophageal cancer [10], stage III colon cancer [11], hepatocellular carcinoma [12] and high-grade glioma [13].